Industry News & Blogs
Philadelphia Facial Plastic Surgeon Dr. Jonathan Pontell Launches Upgraded Website | PRLog
Philadelphia Facial Plastic Surgeon Dr. Jonathan Pontell Launches Upgraded Website. Dr. Jonathan Pontell, Philadelphia facial cosmetic surgery provider, launches updated website with procedure information, including face lift and rhinoplasty. - PR11798071
Philadelphia Facial Plastic Surgeon Dr. Jonathan Pontell Launches Upgraded Website
Dr. Jonathan Pontell, Philadelphia facial cosmetic surgery provider, launches updated website with procedure information, including face lift and rhinoplasty.
ZIOPHARM Oncology Inc Reports Positive Preliminary
NEW YORK, Feb. 13, 2012 -- ZIOPHARM Oncology, Inc. , a biopharmaceutical company with small molecule and synthetic biology approaches to new cancer
amednews: RUC adds 2 seats for primary care :: Feb. 13, 2012 ... American Medical News
An American Geriatrics Society representative and a primary care physician will join the 29-member board that helps the government set Medicare rates.
NICE guidance on dasatinib, high-dose imatinib, and nilotinib for patients with CML who are
NICE guidance on dasatinib, high-dose imatinib, and nilotinib for patients with CML who are resistant or intolerant to imatinib. By - Scott Goulden, Frances Sutcliffe, Andrew Stevens
David Eisele Named Director of Otolaryngology- Head and Neck Surgery at The Johns Hopkins Hospital
David W. Eisele, M.D., has been appointed the new director of Otolaryngology—Head and Neck Surgery at The Johns Hopkins Hospital and the Andelot Professor of Laryngology and Otology at the Johns Hopkins University School of Medicine. He will begin his tenure on March 1, 2012.
Ronnie Andrews, Life Technologi | Life Technologies appoints president of medical sciences |
Life Technologies announced that Ronnie Andrews, former CEO of Clarient and Segment Leader, GE Molecular Diagnostics, has joined the company as president, medical sciences.
Study: Rapid bone loss as possible side effect of anti-obesity drug now in clinical trials
An endocrine hormone used in clinical trials as an anti-obesity and anti-diabetes drug causes significant and rapid bone loss in mice, raising concerns about its safe use, UT Southwestern Medical Center researchers have shown.
U.S. Market for Video, High-Tech and Integrated OR 2012 | SYS-CON MEDIA
SYS-CON Media, NJ, The world's leading i-technology media company on breaking technology news.
Mednax's CEO Discusses Q4 2011 Results - Earnings Call Transcript - Seeking Alpha
< p > Mednax Inc. ( < a href='http://seekingalpha.com/symbol/md' title='Mednax, Inc.' > MD < /a > ) < /p > < p > Q4 2011 Earnings Call < /p > < p > February 02, 2012 10:00 am ET < /p > < p > < strong > Executives < /strong > < /p > < p > David Parker – Vice President of Investor Relations < /p > <
Refine by Topic:
Refine by Content Type:
Refine by Source:
- www.thelancet.com (14,415)
- download.thelancet.com (4,556)
- www.prlog.org (2,298)
- www.medpagetoday.com (2,256)
- www.bioportfolio.co.uk (1,983)
- www.em-consulte.com (1,180)
- www.prweb.com (805)
- www.aerzteblatt.de (502)
- www.australiandoctor.com.au (293)
- imt.ie (262)
- blogs.webmd.com (210)
- www.egms.de (166)
